Cargando…

Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection

Direct-acting antivirals for hepatitis C virus infection may revolutionize treatment among persons with substance use disorders. Despite persons with substance use disorders having the highest hepatitis C virus prevalence and incidence, the vast majority have not engaged into care for the infection....

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez, Stevan A., Fierer, Daniel S., Talal, Andrew H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491232/
https://www.ncbi.nlm.nih.gov/pubmed/28701904
http://dx.doi.org/10.1097/ADT.0000000000000104
_version_ 1783247106599813120
author Gonzalez, Stevan A.
Fierer, Daniel S.
Talal, Andrew H.
author_facet Gonzalez, Stevan A.
Fierer, Daniel S.
Talal, Andrew H.
author_sort Gonzalez, Stevan A.
collection PubMed
description Direct-acting antivirals for hepatitis C virus infection may revolutionize treatment among persons with substance use disorders. Despite persons with substance use disorders having the highest hepatitis C virus prevalence and incidence, the vast majority have not engaged into care for the infection. Previously, interferon-based treatments, with substantial side effects and the propensity to exacerbate mental health conditions, were major disincentives to pursuit of care for the infection. Direct-acting antivirals with viral eradication rates of >90%, significantly improved side effect profiles, and shorter treatment duration are dramatic improvements over prior treatment regimens that should promote widespread hepatitis C virus care among persons with substance use disorders. The major unmet need is strategies to promote persons with substance use disorders engagement into care for hepatitis C virus. Although physical integration of treatment for substance use and co-occurring conditions has been widely advocated, it has been difficult to achieve. Telemedicine offers an opportunity for virtual integration of behavioral and medical treatments that could be supplemented by conventional interventions such as hepatitis C virus education, case management, and peer navigation. Furthermore, harm reduction and strategies to reduce viral transmission are important to cease reinfection among persons with substance use disorders. Widespread prescription of therapy for hepatitis C virus infection to substance users will be required to achieve the ultimate goal of global virus elimination. Combinations of medical and behavioral interventions should be used to promote persons with substance use disorders engagement into and adherence with direct-acting antiviral-based treatment approaches. Ultimately, either physical or virtual colocation of hepatitis C virus and substance use treatment has the potential to improve adherence and consequently treatment efficacy.
format Online
Article
Text
id pubmed-5491232
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-54912322017-07-10 Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection Gonzalez, Stevan A. Fierer, Daniel S. Talal, Andrew H. Addict Disord Their Treat CME Article Direct-acting antivirals for hepatitis C virus infection may revolutionize treatment among persons with substance use disorders. Despite persons with substance use disorders having the highest hepatitis C virus prevalence and incidence, the vast majority have not engaged into care for the infection. Previously, interferon-based treatments, with substantial side effects and the propensity to exacerbate mental health conditions, were major disincentives to pursuit of care for the infection. Direct-acting antivirals with viral eradication rates of >90%, significantly improved side effect profiles, and shorter treatment duration are dramatic improvements over prior treatment regimens that should promote widespread hepatitis C virus care among persons with substance use disorders. The major unmet need is strategies to promote persons with substance use disorders engagement into care for hepatitis C virus. Although physical integration of treatment for substance use and co-occurring conditions has been widely advocated, it has been difficult to achieve. Telemedicine offers an opportunity for virtual integration of behavioral and medical treatments that could be supplemented by conventional interventions such as hepatitis C virus education, case management, and peer navigation. Furthermore, harm reduction and strategies to reduce viral transmission are important to cease reinfection among persons with substance use disorders. Widespread prescription of therapy for hepatitis C virus infection to substance users will be required to achieve the ultimate goal of global virus elimination. Combinations of medical and behavioral interventions should be used to promote persons with substance use disorders engagement into and adherence with direct-acting antiviral-based treatment approaches. Ultimately, either physical or virtual colocation of hepatitis C virus and substance use treatment has the potential to improve adherence and consequently treatment efficacy. Lippincott Williams & Wilkins 2017-06 2017-05-17 /pmc/articles/PMC5491232/ /pubmed/28701904 http://dx.doi.org/10.1097/ADT.0000000000000104 Text en Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
spellingShingle CME Article
Gonzalez, Stevan A.
Fierer, Daniel S.
Talal, Andrew H.
Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection
title Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection
title_full Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection
title_fullStr Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection
title_full_unstemmed Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection
title_short Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection
title_sort medical and behavioral approaches to engage people who inject drugs into care for hepatitis c virus infection
topic CME Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491232/
https://www.ncbi.nlm.nih.gov/pubmed/28701904
http://dx.doi.org/10.1097/ADT.0000000000000104
work_keys_str_mv AT gonzalezstevana medicalandbehavioralapproachestoengagepeoplewhoinjectdrugsintocareforhepatitiscvirusinfection
AT fiererdaniels medicalandbehavioralapproachestoengagepeoplewhoinjectdrugsintocareforhepatitiscvirusinfection
AT talalandrewh medicalandbehavioralapproachestoengagepeoplewhoinjectdrugsintocareforhepatitiscvirusinfection